|
TransAct Technologies Incorporated (TACT) DCF Valuation
US | Technology | Computer Hardware | NASDAQ
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
TransAct Technologies Incorporated (TACT) Bundle
Simplify TransAct Technologies Incorporated (TACT) valuation with this customizable DCF Calculator! Featuring real TransAct Technologies Incorporated (TACT) financials and adjustable forecast inputs, you can test scenarios and uncover TransAct Technologies Incorporated (TACT) fair value in minutes.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 45.7 | 30.6 | 39.4 | 58.1 | 72.6 | 85.0 | 99.5 | 116.4 | 136.3 | 159.5 |
| Revenue Growth, % | 0 | -33.12 | 28.73 | 47.61 | 24.93 | 17.04 | 17.04 | 17.04 | 17.04 | 17.04 |
| EBITDA | 1.8 | -6.7 | -5.0 | -6.4 | 7.2 | -5.4 | -6.3 | -7.4 | -8.6 | -10.1 |
| EBITDA, % | 3.86 | -21.89 | -12.62 | -10.94 | 9.91 | -6.34 | -6.34 | -6.34 | -6.34 | -6.34 |
| Depreciation | 1.4 | 1.3 | 1.0 | 1.3 | 1.5 | 2.4 | 2.8 | 3.3 | 3.9 | 4.5 |
| Depreciation, % | 3 | 4.39 | 2.43 | 2.29 | 2.05 | 2.83 | 2.83 | 2.83 | 2.83 | 2.83 |
| EBIT | .4 | -8.0 | -5.9 | -7.7 | 5.7 | -7.8 | -9.1 | -10.7 | -12.5 | -14.6 |
| EBIT, % | 0.86343 | -26.28 | -15.05 | -13.23 | 7.86 | -9.17 | -9.17 | -9.17 | -9.17 | -9.17 |
| Total Cash | 4.2 | 10.4 | 19.5 | 7.9 | 12.3 | 20.9 | 24.5 | 28.7 | 33.5 | 39.3 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 7.4 | 3.5 | 9.1 | 15.4 | 9.8 | 15.4 | 18.1 | 21.1 | 24.7 | 29.0 |
| Account Receivables, % | 16.25 | 11.36 | 23.09 | 26.53 | 13.53 | 18.15 | 18.15 | 18.15 | 18.15 | 18.15 |
| Inventories | 12.1 | 11.3 | 7.7 | 12.0 | 17.8 | 21.8 | 25.5 | 29.8 | 34.9 | 40.9 |
| Inventories, % | 26.45 | 36.89 | 19.6 | 20.69 | 24.45 | 25.62 | 25.62 | 25.62 | 25.62 | 25.62 |
| Accounts Payable | 3.0 | 1.7 | 4.3 | 7.4 | 4.4 | 7.1 | 8.3 | 9.7 | 11.4 | 13.3 |
| Accounts Payable, % | 6.47 | 5.53 | 10.94 | 12.72 | 6.1 | 8.35 | 8.35 | 8.35 | 8.35 | 8.35 |
| Capital Expenditure | -1.4 | -.7 | -1.4 | -1.3 | -.9 | -2.1 | -2.5 | -2.9 | -3.4 | -4.0 |
| Capital Expenditure, % | -2.99 | -2.43 | -3.51 | -2.23 | -1.24 | -2.48 | -2.48 | -2.48 | -2.48 | -2.48 |
| Tax Rate, % | 19.57 | 19.57 | 19.57 | 19.57 | 19.57 | 19.57 | 19.57 | 19.57 | 19.57 | 19.57 |
| EBITAT | .6 | -5.5 | -4.0 | -5.8 | 4.6 | -6.1 | -7.1 | -8.4 | -9.8 | -11.4 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -16.0 | -1.4 | -3.8 | -13.3 | 2.1 | -12.8 | -11.9 | -13.9 | -16.3 | -19.1 |
| WACC, % | 12.29 | 12.08 | 12.06 | 12.12 | 12.15 | 12.14 | 12.14 | 12.14 | 12.14 | 12.14 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -51.8 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -19 | |||||||||
| Terminal Value | -192 | |||||||||
| Present Terminal Value | -108 | |||||||||
| Enterprise Value | -160 | |||||||||
| Net Debt | -8 | |||||||||
| Equity Value | -152 | |||||||||
| Diluted Shares Outstanding, MM | 10 | |||||||||
| Equity Value Per Share | -15.15 |
What You Will Receive
- Pre-Filled Financial Model: TransAct Technologies' actual data facilitates accurate DCF valuation.
- Comprehensive Forecast Control: Modify revenue growth, profit margins, WACC, and other essential parameters.
- Real-Time Calculations: Automatic updates allow you to view results instantly as you adjust inputs.
- Investor-Ready Template: A polished Excel file crafted for high-quality valuation presentations.
- Customizable and Reusable: Designed for adaptability, enabling repeated use for in-depth forecasts.
Key Features
- Comprehensive DCF Tool: Offers detailed unlevered and levered DCF valuation frameworks.
- WACC Calculator: Features a pre-designed Weighted Average Cost of Capital sheet with adjustable parameters.
- Customizable Forecast Inputs: Adjust growth rates, capital expenditures, and discount rates as needed.
- Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios for TransAct Technologies Incorporated (TACT).
- Interactive Dashboard and Visuals: Graphical representations highlight key valuation metrics for straightforward analysis.
How It Works
- 1. Download the Template: Obtain and open the Excel file featuring TransAct Technologies Incorporated’s (TACT) preloaded data.
- 2. Adjust Key Assumptions: Modify essential inputs such as growth projections, WACC, and capital expenditures.
- 3. Instant Results: The DCF model automatically computes intrinsic value and NPV in real-time.
- 4. Explore Different Scenarios: Evaluate various forecasts to assess multiple valuation possibilities.
- 5. Present with Assurance: Deliver expert valuation insights to back your strategic decisions.
Why Choose This Calculator for TransAct Technologies Incorporated (TACT)?
- Accuracy: Utilizes real TransAct financials for precise data.
- Flexibility: Allows users to easily test and adjust inputs as needed.
- Time-Saving: Eliminates the need to create a DCF model from the ground up.
- Professional-Grade: Crafted with the precision and usability expected by CFOs.
- User-Friendly: Intuitive design, accessible even for those lacking advanced financial modeling skills.
Who Should Use TransAct Technologies Incorporated (TACT)?
- Investors: Gain insights and make informed decisions with advanced transaction technology solutions.
- Financial Analysts: Streamline your analysis with customizable tools tailored for transaction processing.
- Consultants: Easily modify resources for client deliverables or strategic recommendations.
- Tech Enthusiasts: Explore cutting-edge innovations in transaction technologies and their applications.
- Educators and Students: Utilize as a resource for understanding technology's impact on financial transactions.
What the Template Contains
- Pre-Filled Data: Includes TransAct Technologies Incorporated’s (TACT) historical financials and forecasts.
- Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations.
- Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on custom inputs.
- Key Financial Ratios: Analyze TransAct Technologies Incorporated’s (TACT) profitability, efficiency, and leverage.
- Customizable Inputs: Edit revenue growth, margins, and tax rates with ease.
- Clear Dashboard: Charts and tables summarizing key valuation results.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.